PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Jul-2024 Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG
25-Jul-2024 Almac Pharma Services Announces Successful FDA Inspection at Charnwood, UK Facilities Almac Pharma Services
25-Jul-2024 Chiesi marks the return of the You, Me & COPD roadshow in 2024 Chiesi
25-Jul-2024 Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience Mainz BioMed N.V.
25-Jul-2024 Drägerwerk AG & Co. KGaA: Dräger on track to meet annual forecast after a solid first half-year Drägerwerk AG & Co. KGaA
25-Jul-2024 Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members Lonza Group AG
25-Jul-2024 Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB Curatis Holding AG
25-Jul-2024 Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin Lonza Group AG
24-Jul-2024 Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024 Medacta Group SA
24-Jul-2024 ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors ImmunOs Therapeutics
24-Jul-2024 New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE®/MYSIMBA® Amidst GLP-1 Supply Issues Currax Pharmaceuticals LLC
24-Jul-2024 Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec (news with additional features) Immunic AG
24-Jul-2024 DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOPMENT OF ITS RADIO-IMMUNO-CONJUGATES PROGRAM Defence Therapeutics Inc.
22-Jul-2024 Galenica increases shareholding in Redcare Pharmacy to 10% Galenica AG
22-Jul-2024 Secarna Pharmaceuticals publishes new data in Nucleic Acid Therapeutics showcasing strategies to detect and prevent immunostimulatory potential of LNA-modified ASOs Secarna Pharmaceuticals GmbH & Co. KG
22-Jul-2024 Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia Biophytis
22-Jul-2024 Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee. Spexis AG
19-Jul-2024 NICE issues draft guidance on bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma after three treatments Johnson & Johnson
18-Jul-2024 Half-year results 2024 of SartoriusStedimBiotech Sartorius Stedim Biotech SA
17-Jul-2024 Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer Veranova